DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+14.86%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.58B
AUM Growth
+$2.58B
(+6.7%)
Cap. Flow
-$223M
Cap. Flow
% of AUM
-8.64%
Top 10 Holdings %
Top 10 Hldgs %
35.34%
Holding
118
New
12
Increased
13
Reduced
28
Closed
12
Top Buys
| 1 |
Gilead Sciences
GILD
|
$81.7M |
| 2 |
McKesson
MCK
|
$34M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$29.4M |
| 4 |
AnaptysBio
ANAB
|
$23.5M |
| 5 |
LOXO
Loxo Oncology, Inc
LOXO
|
$21.1M |
Top Sells
| 1 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$126M |
| 2 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$60.8M |
| 3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$47.3M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
$32.6M |
| 5 |
Humana
HUM
|
$26.6M |
Sector Composition
| 1 | Healthcare | 71.6% |
| 2 | Financials | 2.56% |
